Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Trogocytosis-mediated tumor relapse after CAR-NK cell therapy prevented by inhibitory CARs

CAR-mediated trogocytosis contributes to dysfunction of natural killer (NK) cells by promoting fratricide and is an important mechanism of relapse after CAR-NK cell therapy. This problem can be overcome using a dual-CAR strategy that incorporates a dominant-negative signal to prevent NK cell fratricide and exhaustion, while sparing the CAR-activating signal against tumor targets.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Inhibitory CAR-based strategy to overcome the deleterious effect of aCAR-mediated trogocytosis in NK cells.

References

  1. June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med 379, 64–73 (2018). A review article on CAR-engineered immune effector cells for the treatment of cancer.

    Article  CAS  Google Scholar 

  2. Liu, E. et al. Use of CAR-Transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 382, 545–553 (2020). This paper reports the ‘first-in-human’ clinical trial of anti-CD19 CAR and IL-15-transduced NK cells for the treatment of patients with lymphoid malignancies.

    Article  CAS  Google Scholar 

  3. Hamieh, M. et al. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature 568, 112–116 (2019). This paper reports CAR-mediated trogocytosis and its effect on CAR-T cell function.

    Article  CAS  Google Scholar 

  4. Joly, E. & Hudrisier, D. What is trogocytosis and what is its purpose? Nat. Immunol. 4, 815 (2003). A review article on the mechanism and biological effect of trogocytosis on the immune system.

    Article  CAS  Google Scholar 

  5. Long, E. O., Kim, H. S., Liu, D., Peterson, M. E. & Rajagopalan, S. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31, 227–258 (2013). A review article that focuses on the regulation of NK cell activity through integration of inhibitory and activating signals.

    Article  CAS  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Li, Y. et al. KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat. Med. https://doi.org/10.1038/s41591-022-02003-x (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Trogocytosis-mediated tumor relapse after CAR-NK cell therapy prevented by inhibitory CARs. Nat Med 28, 2013–2014 (2022). https://doi.org/10.1038/s41591-022-02009-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-02009-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing